Glutathione S-transferases as risk factors in prostate cancer

European Journal of Cancer Prevention

Volumn 8, Issue 6, 1999, Pages 525-532

  Autrup, J L C ^a   Thomassen, L H ^b   Olsen, J H ^b   Wolf, H ^c   Autrup, H ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cancer; Glutathione S transferase; Polymorphism; Prostate

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; ENZYME ACTIVITY; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GLUTATHIONE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING;

EID: 0033391299     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199912000-00008     Document Type: Article

References (46)

1. Aronson KJ, Siemieatyck J, Dewar R, Gérin M (1996). Occupational risk factors for prostate cancer: results from a case-control study in Montréal, Québec, Canada. Am J Epidemiol 143: 363-73.
2. Autrup H, Daneshvar B, Dragsted LO et al. (1999). Biomarkers for exposure to ambient air pollution - comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress. Environ. Health Perspec 107: 233-8.
3. Board PG, Weber GC, Coggan M (1989). Isolation of a cDNA clone and localisation of the human Glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 53: 205-13.
4. Breslow NE, Day NE (1980). Statistical Methods in Cancer Research, Volume 1. The Analysis of Case-Control Studies. IARC Scientific Publication No. 340. International Agency for Research on Cancer, Lyon.
5. Brooks JD, Weinstein M, Lin X et al. (1998). CG island methylation changes near the GSTPI gene in prostatic intraepithelial neoplasia. Cancer Epi Biomarker Prev 7: 531-6.
6. Chen H, Sandler DP, Taylor JA et al. (1996). Increased risk for myelodysplastic syndromes among those with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347: 295-7.
7. Conney K, McCarthy J, Lange E et al. (1997). Prostate cancer susceptibility locus on chromosome 1q. A confirmatory study. J Natl Cancer Inst 89: 955-9.
8. Dai WS, Gutai JP, Kuller LH, Canley JA (1988). Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128: 796-805.
9. DeWeese TL, Shipman JM, Buckley NM, Thomas R, Nelson WG (1998). Inactivation of GSTP1 genes provides a survival advantage following oxidative DNA damage in human prostate cells. AACR Proc 39: 466.
10. Fjellstedt TA, Allen RH, Duncan BK, Jacoby WB (1993). Enzymatic conjugation of epoxides with glutathione. J Biol Chem 248: 3702-7.
11. Gertig DM, Stampfer M, Haiman C et al. (1998). Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemol Biomarker Prev 7: 1001-5.
12. Giovannticci E (1996). How is individual risk for prostate cancer assessed? Hematol Oncol Clin North Am 10: 537-48.
13. Haenzel W, Kurihara M (1968). Studies of Japanese migrants. 1. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43-68.
14. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR (1997). Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18: 641-4.
15. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isozymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
16. Helzlsouer KJ, Selmin O, Huang HY et al. (1998). Association between glutathione S-transferase M1, P1 and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst. 90: 512-18.
17. Henderson CJ, Smith AG, Ure J et al. (1998). Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc Nat Acad Sci (USA) 95: 5275-80.
18. Hu X, Ji X, Srivastava SK et al. (1997). Mechanism of differential catalytic efficiency of the two polymorphic forms of the human glutathione S-transferase PI-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 345: 32-8.
19. Hu X, Xia H, Srivastava SK et al. (1998) Catalytic efficiencies of allelic variants of human glutathione S-transferase PI-1 towards carcinogenic anti-diol epoxides of benzo [c]phenan-threne and benzo[g]chrysene. Cancer Res 58: 5340-3.
20. Jourenkova N, Reinikainen M, Bouchardy C et al. (1998). Larynx cancer risk in relation to glutathionc S-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol Biomarker Prev 7: 19-23.
21. Katoh T, Nagata N, Kuroda Y et al. (1996). Glutatione S-transferase M1 (GSTM1) and T1 (GSTY1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17: 1855-9.
22. Kihara M, Kihara M, Noda K (1994). Lung cancer risk of GSTM1 null genotype is dependent on the extent of cigarette smoke exposure. Carcinogenesis 15: 415-18.
23. Knudsen LE, Norppa H, Gamborg MO et al. (1999). Chromosomal aberrations in humans induced by urban air pollution: Influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epi Biomarker Prev 8: 303-10.
24. Lear JT, Smith AG, Heagerty AHM et al. (1997). Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma. Carcinogenesis 18: 1499-503.
25. Lumey LH, Pittman B, Zang EA, Wynder EL (1997). Cigarette smoking and prostate cancer: No relationship with six measures of lifetime smoking habits in a large case-control study among US while. Phostate 33: 195-200.
26. Lunn R, Taylor J, Mohler J, Bell DA (1998). Steroid related genes, CYP17 and SRD52A, and prostate cancer. Proc AACR 39: 626.
27. Matzkin H, Soloway MS (1993). Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate 22: 277-190.
28. McWilliams JE, Sanderson BJS, Harris EL, Richert-Boe KE, Henner WD (1995). Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarker Prev 4: 589-94.
29. Moffat GJ, McLaren AW, Wolf CR (1997), Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene. Biochem J 324: 91-5.
30. Moskaluk CA, Duray PH, Cowan KH, Linchan M, Merino MJ (1997). Immunohistochemical expression of Pi-class glutathione S-transferase is down regulated in adenocarcinoma of the prostate. Cancer 79: 1595-9.
31. Nelson HH, Wiencke JK, Christiani DC et al. (1995). Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 16: 1243-5.
32. Noble RL (1977). The development of prostatic carcinoma in NB rats following prolonged sex hormone administration. Cancer Res 37: 1929-33.
33. Okkels H, Sigsgaard T, Wolf H, Autrup H (1996). Glutathione S-transferase λ as a risk factor in bladder tumours. Pharmacogenetics 6: 251-6.
34. Pemble S, Schroeder KR, Spencer SR et al. (1994). Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300: 271-6.
35. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 cancer susceptibility. Cancer Epidemiol Biomarker Prev 6: 733-43.
36. Rebbeck TR, Jaffe JM, Walker AH, Wein AJ, Maikowicz SB (1998). Modification of clinical presentation of prostate tumors by the novel genetic variant in CYP3A4. J Natl Cancer Inst 90: 1225-9.
37. Rodriguez C, Thatham LM, Thun MJ, Eugenia EE, Heath CW (1997). Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol 145: 466-75.
38. Ryberg D, Skaug V, Hewer A et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adducts and cancer risk. Carcinogenesis 18: 1285-9.
39. Salagovic J, Kalina I, Stubna J et al. (1998). Genetic polymorphism of glulathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasms 45: 312-17.
40. Spurr NK, Gough AC, Smith CAD, Wolf CR (1991). Genetic analysis of cytochrome P450 system. Methods Enzymol. 206: 149-66.
41. Strange RC, Lear JT, Fryer AA (1998). Polymorphism in glutathione S-transferase loci as a risk factor for common cancers. Arch Toxicol. 20: 419-28.
42. Strom SS, Spitz MR, Guan Y et al. (1998). Reduced expression of DNA-repair related genes in prostate cancer. Proc AACR, 39: 181.
43. Sundberg K, Johansson A-S, Stenberg G et al. (1998). Differences in the catalytic efficiencies of allelic variants of glutathione transferase PI-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 19: 433-6.
44. To-Figueras J, Gené, M, Gómez-Catalán J et al. (1997). Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphims and lung cancer risk among north-western Mediterraneans. Carcinogenesis 18: 1529-33.
45. Wadelius M, Autrup JL, Stubbins MJ et al. (1999). Polymorphisms in NAT2, CYP2D6, CYP2C19, GSTP1, and their association with prostate cancer. Pharmacogenetics 9: 330-40.
46. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA (1998). Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19: 275-80.